Detection of Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant HIV‐1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy
Open Access
- 1 August 2008
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (3), 421-424
- https://doi.org/10.1086/589867
Abstract
Using standard and ultrasensitive techniques, we detected nonnucleoside reverse-transcriptase inhibitor-associated resistance mutations in 11 (20%) oKeywords
This publication has 16 references indexed in Scilit:
- Interruption of Antiretroviral Treatment in HIV‐Infected Patients with Preserved Immune Function Is Associated with a Low Rate of Clinical Progression: A Prospective Study by AIDS Clinical Trials Group 5170The Journal of Infectious Diseases, 2007
- Pilot Study of a Novel Short-Cycle Antiretroviral Treatment Interruption Strategy: 48-Week Results of the Five-Days-On, Two-Days-Off (FOTO) StudyHIV Research & Clinical Practice, 2007
- Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmissionProceedings of the National Academy of Sciences of the United States of America, 2006
- Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapyAIDS, 2006
- Correlates of Self-Reported Nonadherence to Antiretroviral Therapy in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Pharmacokinetic Parameters of Nevirapine and Efavirenz in Relation to Antiretroviral EfficacyAIDS Research and Human Retroviruses, 2006
- Long-term persistence of HIV with drug resistance after CD4 cell count-guided structured treatment interruptionAIDS, 2005
- Comparison of Oligonucleotide Ligation Assay and Consensus Sequencing for Detection of Drug-Resistant Mutants of Human Immunodeficiency Virus Type 1 in Peripheral Blood Mononuclear Cells and PlasmaJournal of Clinical Microbiology, 2004
- A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV InfectionThe Journal of Infectious Diseases, 2004
- Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic ParametersThe Journal of Infectious Diseases, 2003